Compounds and pharmaceutical uses of peptides of bombesin and GRP
US5834433A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Feb 23, 1996 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | Feb 23, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/086
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method for controlling the growth of tumor tissues, especially small cell lung. Treatment comprises administering to a patient in need thereof, an effective amount of a bombesin/GRP type inhibitor. Antagonists of bombesin/GRP which are derivatives of naturally occurring bombesin/GRP possessing a thiomethylene or methylene sulfoxide bond connecting the two amino acids on the carboxy terminal end is modified are described. The antagonism is confirmed using conventional competitive binding and biochemical assays as well as conventional physiological tests and the use of these derivatives in a variety of conditions in which bombesin/GRP is implicated is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.